Shinagawa LASIK & Aesthetics: Pursuing a Clear Vision | Lifestyle.INQ

OCTOBER 27, 2022

MANILA, Philippines – Five years ago, Shinagawa Lasik & Aesthetics opened its doors in Manila. Nestled in the heart of Makati’s Central Business District, the clinic marked the Japanese clinic’s first business operation outside of Japan where it has established itself as the no.1 Aesthetic surgery clinic.

Over the past 25 years, Shinagawa has cemented their status as the most advanced LASIK surgery clinic, serving over 3 Million satisfied patients, all while ensuring the safest and highest level of treatment at a very reasonable price.

Their LASIK services include Z-LASIK, IntraLASIK and PresbyLASIK. All types of Lasik work by reshaping the part of the eye responsible for refraction to correct errors in vision such as Nearsightedness, Farsightedness, Astigmatism or Presbyopia (visual impairment associated with aging).

Mica Javier - Satisfied Lasik Patient

While these Lasik procedures bear similarities with one another, mostly in the way they are performed, they differ in their indications and methods used.

Another visual corrective procedure which Shinagawa offers is Corneal Collagen Cross Linking (an alternative to Corneal Surgery). This is often used as a means of strengthening the eye in preparation for further LASIK treatment.

Shinagawa’s growing family of experts and highly trained medical practitioners in the fields of Ophthalmology, Aesthetic Medicine and Orthodontics (trained in both the Philippines and Japan) continue to maintain consistent excellence in rendering world-class Medical care and Aesthetic services, providing the best, safest, most accessible and affordable services not only to Filipinos but to the rest of the world. ADVT


Shinagawa Lasik & Aesthetics is located at Mezzanine, Tower 2, The Enterprise Center, 6766 Ayala ave. cor. Paseo de Roxas, 1226, Makati City, Philippines. For inquiries, call 491-0000 / 846-3197 or visit


Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.